10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q1 2015

Filing Information

Form Type	10-Q
Accession Number	`0001564590-15-000557`
Period End Date	20141231
Filing Date	20150209
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	arwr-20141231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 85 Income Statement 40 Cash Flow Statement 65 Stockholders Equity 22

Balance Sheet 85 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$103.99M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$59.71M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	18,300.00	shares	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$127.00K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	18,300.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$4.45M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	18,300.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	18,300.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$588.63K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$48.50K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$62.84K	USD	Point-in-time
Short term investments	`MarketableSecuritiesCurrent`	$23.53M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Short term investments	`MarketableSecuritiesCurrent`	$21.65M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$154.80M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$132.16M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	54.72M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	54.66M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	54.72M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	54.66M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.12M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.87M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$999.81K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$3.24M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.01M	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$23.09M	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$17.81M	USD	Point-in-time
Other assets	`OtherAssetsMiscellaneousNoncurrent`	$41.41K	USD	Point-in-time
Other assets	`OtherAssetsMiscellaneousNoncurrent`	$7.04M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$162.14M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$182.82M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.99M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.58M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.40M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.15M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$2.18M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$3.27M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$103.12K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$109.38K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$1.79M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$4.17M	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$213.99K	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$213.99K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$50.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$58.49K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$65.21K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$11.85M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$11.50M	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$758.34K	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$705.17K	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiability`	$3.97M	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiability`	$1.60M	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiability`	$3.97M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$253.32K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$255.21K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$4.98M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$4.93M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 18,300 and 18,300 shares issued and outstanding as of December 31, 2014 and September 30, 2014, respectively	`PreferredStockValue`	$18.00	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 18,300 and 18,300 shares issued and outstanding as of December 31, 2014 and September 30, 2014, respectively	`PreferredStockValue`	$18.00	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 54,715,714 and 54,656,936 shares issued and outstanding as of December 31, 2014 and September 30, 2014, respectively	`CommonStockValue`	$147.09K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 54,715,714 and 54,656,936 shares issued and outstanding as of December 31, 2014 and September 30, 2014, respectively	`CommonStockValue`	$147.03K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$391.16M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$393.46M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-247.35M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-224.77M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$166.54M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$146.26M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$145.71M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$165.99M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$182.82M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$162.14M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	$170.75K	USD	1 Quarter
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.13M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$17.74M	USD	1 Quarter
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$3.15M	USD	1 Quarter
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$2.08M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$913.78K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.09M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.01M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$521.14K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$403.40K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$290.04K	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$7.05M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$25.29M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-7.01M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-25.12M	USD	1 Quarter
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-138.46K	USD	1 Quarter
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-26.38K	USD	1 Quarter
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-53.56K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$40.58K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$237.42K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-3.52M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$2.38M	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-5.33K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-53.18K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$2.54M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$-3.68M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-22.58M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-10.69M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-10.69M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-58.73M	USD	Annual
NET LOSS	`ProfitLoss`	$-22.58M	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-57.42K	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-22.58M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-10.63M	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.28	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	54.69M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	37.74M	shares	1 Quarter

Cash Flow Statement 65 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-10.69M	USD	1 Quarter
Net loss	`ProfitLoss`	$-58.73M	USD	Annual
Net loss	`ProfitLoss`	$-22.58M	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-57.42K	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-22.58M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-10.63M	USD	1 Quarter
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-26.38K	USD	1 Quarter
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-53.56K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-3.52M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$2.38M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.01M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$521.14K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$403.40K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$290.04K	USD	1 Quarter
Amortization/accretion of note premiums/discounts, net	`AmortizationOfDebtDiscountPremium`	$347.70K	USD	1 Quarter
Amortization/accretion of note premiums/discounts, net	`AmortizationOfDebtDiscountPremium`	$28.44K	USD	1 Quarter
Non-controlling interest	`NoncontrollingInterest`	$57.42K	USD	1 Quarter
Non-controlling interest	`NoncontrollingInterest`	-	USD	1 Quarter
Receivables	`IncreaseDecreaseInReceivables`	$127.00K	USD	1 Quarter
Receivables	`IncreaseDecreaseInReceivables`	$11.82K	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	$9.51K	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$74.45K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$3.87M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-610.28K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.42M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$56.65K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.33M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-222.81K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-802.00	USD	1 Quarter
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-7.02M	USD	1 Quarter
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-24.20M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$554.95K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$116.22K	USD	1 Quarter
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	1 Quarter
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$500.00	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$19.08M	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	-	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$4.05M	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.05M	USD	1 Quarter
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	1 Quarter
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$7.00M	USD	1 Quarter
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-15.15M	USD	1 Quarter
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-4.50M	USD	1 Quarter
Principal payments on capital leases and notes payable	`RepaymentsOfLongTermCapitalLeaseObligations`	$103.17K	USD	1 Quarter
Principal payments on capital leases and notes payable	`RepaymentsOfLongTermCapitalLeaseObligations`	$54.72K	USD	1 Quarter
Proceeds from issuance of common stock and preferred stock, net	`ProceedsFromIssuanceOrSaleOfEquity`	$62.82M	USD	1 Quarter
Proceeds from issuance of common stock and preferred stock, net	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	1 Quarter
Proceeds from the exercise of warrants and stock options	`ProceedsFromExerciseOfWarrantsAndStockOptions`	-	USD	1 Quarter
Proceeds from the exercise of warrants and stock options	`ProceedsFromExerciseOfWarrantsAndStockOptions`	$283.47K	USD	1 Quarter
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$62.77M	USD	1 Quarter
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$180.30K	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-28.52M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$40.60M	USD	1 Quarter
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$103.99M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$59.71M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$103.99M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$59.71M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
Interest paid	`InterestPaid`	$9.50K	USD	1 Quarter
Interest paid	`InterestPaid`	$3.94K	USD	1 Quarter

Stockholders Equity 22 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$145.71M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$165.99M	USD	Point-in-time
Exercise of warrants, Amount	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$10.15M	USD	Annual
Exercise of warrants, Amount	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$270.62K	USD	1 Quarter
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.73M	USD	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$12.98K	USD	1 Quarter
Stock options exercised	`StockIssuedDuringPeriodSharesStockOptionsExercised`	454,863.00	shares	Annual
Stock options exercised	`StockIssuedDuringPeriodSharesStockOptionsExercised`	2,500.00	shares	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.70M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.01M	USD	1 Quarter
Exercise of exchange rights, Amount	`ExchangeRightsExercisedDuringPeriodValue`	$1.24K	USD	1 Quarter
Stock issuances, Shares	`StockIssuedDuringPeriodSharesNewIssues`	3.07M	shares	Point-in-time
Stock issuances, Shares	`StockIssuedDuringPeriodSharesNewIssues`	6.33M	shares	Point-in-time
Settlements related to derivative liability	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$5.96M	USD	Annual
Deconsolidation of Calando Pharmaceuticals, Inc.	`NoncontrollingInterestDecreaseFromDeconsolidation`	$1.30M	USD	Annual
Net loss	`ProfitLoss`	$-10.69M	USD	1 Quarter
Net loss	`ProfitLoss`	$-58.73M	USD	Annual
Net loss	`ProfitLoss`	$-22.58M	USD	1 Quarter
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$145.71M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$165.99M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.